Company Overview of Foley Hoag LLP
Foley Hoag LLP provides legal advisory services. The firm’s practice areas include dispute resolution, antitrust, bankruptcy and restructuring, litigation, mergers and acquisitions, intellectual property, taxation, trusts and estates, labor and employment law, patent and trademark, immigration, and trade regulation. It caters to banking, healthcare, technology, telecommunications, real estate, energy, and insurance industries. Foley Hoag LLP was formerly known as Foley, Hoag & Eliot LLP and changed its name on May 28, 2002. The firm was founded in 1943 and is based in Boston, Massachusetts.
155 Seaport Boulevard
Boston, MA 02210-2600
Founded in 1943
Key Executives for Foley Hoag LLP
Managing Partner of Washington DC Office
Partner and Co-Chair of the Government Strategies Group
Compensation as of Fiscal Year 2015.
Foley Hoag LLP Key Developments
Foley Hoag Appoints Susan Abelleira and Alexander Akhiezer as Partners in Intellectual Property Department
Jun 29 15
Susan Abelleira and Alexander Akhiezer Join Foley Hoag as Partners in Intellectual Property Department. Two new partners have joined Foley Hoag LLP's Intellectual Property Department, bringing to the firm extensive scientific backgrounds, patent law expertise in areas ranging from chemistry, to biotechnology, to pharmaceuticals and over 30 years of combined patent law experience. Susan Abelleira and Alexander Akhiezer come to Foley Hoag from intellectual property law firm Hamilton Brook Smith Reynolds, where both were principals. They will be based in Foley Hoag's Boston office. Abelleira's practice focuses on chemical and pharmaceutical industry patent prosecution and patent portfolio development and management. She also assists clients with non-infringement, invalidity and freedom-to-operate opinions, due diligence for investment and acquisition and agreements that involve intellectual property rights. Akhiezer's practice focuses on emerging technologies at the intersection of chemistry, biology, and physics. He advises clients on patent life cycle management as well as investment due diligence around a wide range of products, including pharmaceuticals, composite materials, medical devices, and optical systems such as tomographic devices.
Foley Hoag LLP Opens New Office in New York City; Announces Executive Appointments
May 12 15
Foley Hoag LLP announced opening of an office in New York City and the hiring of three new partners. The three partners starting Foley Hoag's New York office are: Peter Sullivan, Walter Egbert III and Daniel Schimmel. Under their leadership, the office will initially focus on intellectual property and international law and arbitration, two areas of strength for the firm. The firm expects that its New York office will expand over time into other practice areas where the firm excels. Peter Sullivan, formerly a partner at Hughes Hubbard and Reed and formerly the co-chair of the firm's intellectual property practice, is an intellectual property litigator who focuses on patents, copyrights, trademarks, product liability, and commercial litigation and arbitration. Walter Egbert will also be joining from Hughes Hubbard and Reed, and his practice will focus on intellectual property and patent law. Daniel Schimmel focuses his practice on international arbitration, transnational litigation, and internal investigations. Schimmel, formerly a partner at Kelley Drye & Warren LLP and co-Chair of the firm's international arbitration practice.
Scott Kamholz Rejoins Foley Hoag LLP as Partner and Co-Chair of Patent Post Grant Proceedings Practice
May 6 15
Former Administrative Patent Judge of the U.S. Patent Trial and Appeal Board (PTAB) Scott Kamholz will rejoin Foley Hoag LLP as a partner and co-chair of the firm's Patent Post Grant Proceedings Practice. He will practice in the firm's Washington, D.C. office. During his time at the PTAB, Judge Kamholz handled more than 120 inter partes review (IPR) proceedings, the new trial proceedings established by the Leahy-Smith America Invents Act of 2011 (AIA). Judge Kamholz handled trial proceedings in a wide variety of technologies, including pharmaceuticals, biologics and biosimilars, medical devices, polymers, energy production, software, electronics, and business methods. In addition to his legal training, Scott has deep scientific expertise.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|